PALOMAR MEDICAL TECHNOLOGIES INC
8-K, 1999-06-29
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: PHYCOR INC /TN/, 11-K, 1999-06-29
Next: GATEWAY TAX CREDIT FUND III LTD, NT 10-K, 1999-06-29



                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

       Date of report (Date of earliest event reported) November 3, 1998

                       Palomar Medical Technologies, Inc.
- --------------------------------------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)
<TABLE>
<S>                                         <C>                                         <C>

     Delaware                                                                           04-3128178
- -----------------------------------------------------------------------------------------------------------
(State or Other Jurisdiction                (Commission                                 (IRS Employer
     of Incorporation)                      File Number)                                Identification No.)
</TABLE>

45 Hartwell Avenue, Lexington, Massachusetts                          02421-3102
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices)                              (Zip Code)

Registrant's telephone number, including area code   781-676-7300
- --------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


<PAGE>
ITEM 5.  OTHER EVENTS.

         Palomar Medical Technologies, Inc. issued a press release regarding the
preliminary report of the independent  inspector of elections in connection with
the annual  meeting of  stockholders  held on June 23, 1999. A copy of the press
release is attached hereto and incorporated by reference.

ITEM 7.  EXHIBITS.

99.1      Press Release dated June29, 1999.



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                              PALOMAR MEDICAL TECHNOLOGIES, INC.

Date:    June 29, 1999

                                              By: /s/ Louis P. Valente
                                                 -------------------------------
                                              Name:    Louis P. Valente
                                              Title:   President and
                                                       Chief Executive Officer

                                  NEWS RELEASE



                             FOR IMMEDIATE RELEASE


CONTACTS:
John Ingoldsby                          or    Joseph Caruso
Director of Investor Relations                Chief  Financial Officer
Palomar Medical Technologies, Inc.            Palomar Medical Technologies, Inc.
781-402-2411                                  781-676-7300


                    PALOMAR CLAIMS VICTORY IN PROXY CONTEST


LEXINGTON,  Mass., June 29, 1999 - Palomar Medical  Technologies,  Inc. (NASDAQ:
PMTI), the technology  leader in laser hair removal,  today claimed victory over
The  Monterey  Stockholders  Group LLC in the proxy  contest for the election of
directors. The company's announcement was based on the preliminary report of the
independent   Inspector  of  Election  from  the  Company's  annual  meeting  of
stockholders  held on June 23, 1999.  The  Monterey  Group had sought to replace
Palomar's Board of Directors with their own nominees.

The Inspector's  preliminary report noted that  approximately  28,384,054 shares
voted at the meeting voted for Palomar's  nominees and  approximately  9,553,994
shares voted at the meeting voted for Monterey's nominees.  Palomar said that it
achieved the victory despite the actions of Monterey's  members,  including Mark
T. Smith, leader of Monterey,  who intentionally failed to vote their own shares
at the  annual  meeting  in an  unsuccessful  attempt to prevent a quorum at the
meeting and avoid conclusive defeat at the polls.

Louis P. Valente,  chairman and chief executive  officer of Palomar,  said, "The
preliminary  report of the Inspector of Election  demonstrates broad support for
Palomar's  Board of  Directors  by its  stockholders.  We thank  them for  their
support  and pledge to  continue  our  efforts to enhance  value for all Palomar
stockholders."

Valente  continued,  "Monterey's failed actions to prevent a quorum were, in our
opinion, a deliberate attempt to circumvent the voting process,  silence Palomar
stockholders  and avoid  resounding  defeat at the polls. In its effort to avoid
defeat,  Monterey has attempted to thwart the most fundamental principle of good
corporate  governance,  the right of  shareholders  to take  action  through the
voting  process.  In our view,  Mr.  Smith  and his group now have  conclusively
proven to  stockholders  precisely  why they do not deserve to sit on  Palomar's
Board."

Certified,  final voting  results will be issued by the Inspector of Election in
the near future. At that time, final results will be announced.

Palomar Medical  Technologies,  Inc. is a leading supplier of proprietary  laser
systems  for hair  removal  and other  cosmetic  laser  treatments.  Hundreds of
Palomar laser hair removal  systems have been  installed in physician  practices
worldwide, and hundreds of thousands of treatments have been performed.


                                     (more)
<PAGE>

                                                                     PALOMAR / 2

"Safe Harbor" Statement Under the Private Securities Litigation Reform Act
With the exception of the historical  information contained in this release, the
matters described herein contain forward-looking  statements,  including but not
limited to  statements  relating  to the use of  proceeds  of the Star sale that
involve risk and  uncertainties  that may  individually  or mutually  impact the
matters  herein,  and cause actual  results,  events and  performance  to differ
materially.  These risk factors include,  but are not limited to,  technological
difficulties,  lack of  product  demand  and  market  acceptance,  the effect of
economic   conditions,   the  impact  of   competitive   products  and  pricing,
governmental  regulations with respect to medical devices,  and/or other factors
outside the control of the company,  which are detailed from time to time in the
company's  SEC  reports,  including  the  report on Form 10-K for the year ended
December 31, 1998.  Readers are cautioned  not to place undue  reliance on these
forward-looking statements,  which speak only as of the date hereof. The company
undertakes  no  obligation  to release  publicly the result of any  revisions to
these  forward-looking  statements  that  may  be  made  to  reflect  events  or
circumstances   after  the  date  hereof  or  to  reflect  the   occurrence   of
unanticipated events.

                                     # # # #

Palomar news releases are available  through PR Newswire Company News on-Call by
fax at 800-758-5804,  Extension 107555, or http://www.prnewswire.com/(PMTI)  For
more information about Palomar, visit our home page at http://www.palmed.com



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission